NeuroPsy InfoHub adună studii și articole verificate editorial despre sănătate mintală și afecțiuni neurologice — pentru pacienți, familii și specialiști.
Researchers developed a rehabilitation platform combining virtual reality with targeted sensory nerve stimulation for stroke recovery. A randomized clinical trial published in Nature Medicine showed improvements in arm/hand function and tactile awareness, offering potential for more personalized rehabilitation beyond conventional therapy.
This post hoc analysis of a randomized controlled trial in China examined whether liraglutide (a GLP-1 receptor agonist) reduces stroke recurrence differently based on insulin resistance levels in patients with minor ischemic stroke or TIA and type 2 diabetes. Treatment efficacy varied significantly by insulin resistance status, with greater benefit observed in patients with elevated baseline insulin resistance.
This case describes a 26-year-old woman with Eagle syndrome (elongated styloid process) who developed a life-threatening hemorrhagic complication involving an aneurysmal dilatation of the carotid artery, resulting in cervical hematoma with airway compromise and acute ischemic stroke. The patient required emergency airway management and demonstrated the severe vascular consequences possible when the styloid process compresses or injures adjacent blood vessels.
Patients with autoimmune rheumatic diseases (such as lupus and vasculitis) have significantly elevated stroke risk 1.3-2.5 times higher than the general population, often occurring at younger ages due to systemic inflammation and immune-mediated vascular injury. This review synthesizes evidence on stroke pathophysiology, prevention strategies, and post-stroke rehabilitation outcomes specific to rheumatologic populations.
This health economics study analyzed administrative healthcare data from Italian regions to assess direct medical costs for patients with atherosclerotic cardiovascular diseases, including ischemic stroke and transient ischemic attack, along with acute coronary syndrome and peripheral arterial disease. Over a 2-year period, approximately 350,000 patients were hospitalized annually with average direct costs of €7,190 per patient, with hospitalizations comprising nearly 70% of total expenses.
